Epidemiology of Lyme Disease

Infectious Disease Clinics of North America

Volumn 29, Issue 2, 2015, Pages 187-210

  Mead, Paul S ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

Borrelia burgdorferi; Epidemiology; Human; Incidence; Ixodes; Lyme disease; Tick borne diseases; Zoonosis

Indexed keywords

AGE DISTRIBUTION; ASIA; BACTERIAL TRANSMISSION; BACTERIUM IDENTIFICATION; BORRELIA; BORRELIA BAVARIENSIS; BORRELIA BISSETII; BORRELIA BURGDORFERI; BORRELIA LUSITANIAE; BORRELIA SPIELMANII; BORRELIA VALAISIANA; CLINICAL FEATURE; EUROPE; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; IXODES; LYME DISEASE; MORTALITY; NONHUMAN; POPULATION ABUNDANCE; REVIEW; RISK FACTOR; SOUTHERN HEMISPHERE; TICK; UNITED STATES; ANIMAL; DISEASE CARRIER; HEALTH; PREVALENCE; TRANSMISSION;

ANIMALS; GLOBAL HEALTH; HUMANS; INSECT VECTORS; LYME DISEASE; PREVALENCE; RISK FACTORS;

EID: 84929617259     PISSN: 08915520     EISSN: 15579824     Source Type: Journal    
DOI: 10.1016/j.idc.2015.02.010     Document Type: Review

References (149)

1. Steere A.C., Coburn J., Glickstein L. The emergence of Lyme disease. JClin Invest 2004, 113:1093-1101.
2. Piesman J., Gern L. Lyme borreliosis in Europe and North America. Parasitology 2004, 129(Suppl):S191-S220.
3. Steere A.C. Lyme disease. NEngl J Med 2001, 345:115-125.
4. Strle F., Stantic-Pavlinic M. Lyme disease in Europe. NEngl J Med 1996, 334:803.
5. Stanek G., Strle F. Lyme borreliosis. Lancet 2003, 362:1639-1647.
6. Nau R., Christen H.J., Eiffert H. Lyme disease-current state of knowledge. Dtsch Arztebl Int 2009, 106:72-81. I.
7. Steere A.C., Malawista S.E., Snydman D.R., et al. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum 1977, 20:7-17.
8. Steere A.C., Malawista S.E., Hardin J.A., et al. Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum. Ann Intern Med 1977, 86:685-698.
9. Matuschka F.R., Ohlenbusch A., Eiffert H., et al. Antiquity of the Lyme-disease spirochaete in Europe. Lancet 1995, 346:1367.
10. Edlow J.A. Bull's eye. Unraveling the medical mystery of Lyme disease 2003, Yale University Press, New Haven (CT).
11. Rudenko N., Golovchenko M., Grubhoffer L., et al. Borrelia carolinensis sp. nov., a novel species of the Borrelia burgdorferi sensu lato complex isolated from rodents and a tick from the south-eastern USA. Int J Syst Evol Microbiol 2011, 61:381-383.
12. Maraspin V., Ruzic-Sabljic E., Strle F. Lyme borreliosis and Borrelia spielmanii. Emerg Infect Dis 2006, 12:1177.
13. Diza E., Papa A., Vezyri E., et al. Borrelia valaisiana in cerebrospinal fluid. Emerg Infect Dis 2004, 10:1692-1693.
14. de Carvalho I.L., Fonseca J.E., Marques J.G., et al. Vasculitis-like syndrome associated with Borrelia lusitaniae infection. Clin Rheumatol 2008, 27:1587-1591.
15. Rudenko N., Golovchenko M., Mokracek A., et al. Detection of Borrelia bissettii in cardiac valve tissue of a patient with endocarditis and aortic valve stenosis in the Czech Republic. JClin Microbiol 2008, 46:3540-3543.
16. Rudenko N., Golovchenko M., Ruzek D., et al. Molecular detection of Borrelia bissettii DNA in serum samples from patients in the Czech Republic with suspected borreliosis. FEMS Microbiol Lett 2009, 292:274-281.
17. Telford S.R., Mather T.N., Moore S.I., et al. Incompetence of deer as reservoirs of the Lyme disease spirochete. Am J Trop Med Hyg 1988, 39:105-109.
18. Diuk-Wasser M.A., Gatewood A.G., Cortinas M.R., et al. Spatiotemporal patterns of host-seeking Ixodes scapularis nymphs (Acari: Ixodidae) in the United States. JMed Entomol 2006, 43:166-176.
19. Maggi R.G., Reichelt S., Toliver M., et al. Borrelia species in Ixodes affinis and Ixodes scapularis ticks collected from the coastal plain of North Carolina. Ticks Tick Borne Dis 2010, 1:168-171.
20. Oliver J.H., Lin T., Gao L., et al. An enzootic transmission cycle of Lyme borreliosis spirochetes in the southeastern United States. Proc Natl Acad Sci USA 2003, 100:11642-11645.
21. Ginsberg H.S., Rulison E.L., Azevedo A., et al. Comparison of survival patterns of northern and southern genotypes of the North American tick Ixodes scapularis (Acari: Ixodidae) under northern and southern conditions. Parasit Vectors 2014, 7:394.
22. Sakamoto J.M., Goddard J., Rasgon J.L. Population and demographic structure of Ixodes scapularis Say in the eastern United States. PLoS One 2014, 9:e101389.
23. Spielman A., Wilson M.L., Levine J.F., et al. Ecology of Ixodes dammini-borne human babesiosis and Lyme disease. Annu Rev Entomol 1985, 30:439-460.
24. Goddard J. Aten-year study of tick biting in Mississippi: implications for human disease transmission. JAgromedicine 2002, 8:25-32.
25. Lin T., Oliver J.H., Gao L. Comparative analysis of Borrelia isolates from southeastern USA based on randomly amplified polymorphic DNA fingerprint and 16S ribosomal gene sequence analyses. FEMS Microbiol Lett 2003, 228:249-257.
26. Oliver J.H., Gao L., Lin T. Comparison of the spirochete Borrelia burgdorferi s.l. isolated from the tick Ixodes scapularis in southeastern and northeastern United States. JParasitol 2008, 94:1351-1356.
27. Smith R.P., Rand P.W., Lacombe E.H., et al. Role of bird migration in the long-distance dispersal of Ixodes dammini, the vector of Lyme disease. JInfect Dis 1996, 174:221-224.
28. Bacon R.M., Kugeler K.J., Mead P.S. Surveillance for Lyme disease-United States, 1992-2006. MMWR Surveill Summ 2008, 57:1-9.
29. Ertel S.H., Nelson R.S., Cartter M.L. Effect of surveillance method on reported characteristics of Lyme disease, Connecticut, 1996-2007. Emerg Infect Dis 2012, 18:242-247.
30. Ai C.X., Wen Y.X., Zhang Y.G., et al. Clinical manifestations and epidemiological characteristics of Lyme disease in Hailin county, Heilongjiang Province, China. Ann N Y Acad Sci 1988, 539:302-313.
31. Forrester J.D., Meiman J., Mullins J., et al. Notes from the field: update on Lyme carditis, groups at high risk, and frequency of associated sudden cardiac death-United States. MMWR Morb Mortal Wkly Rep 2014, 63:982-983.
32. Busch U., Hizo-Teufel C., Bohmer R., et al. Borrelia burgdorferi sensu lato strains isolated from cutaneous Lyme borreliosis biopsies differentiated by pulsed-field gel electrophoresis. Scand J Infect Dis 1996, 28:583-589.
33. Nadelman R., Auwaerter P., Mumford D. Early Lyme disease: erythema migrans. Infect Dis Clin North Am 2015.
34. Halperin J., Auwaerter P.G., Mumford D. Neuroborreliosis. Infect Dis Clin North Am 2015.
35. Melia M., Auwaerter P., Mumford D., et al. Lyme carditis. Infect Dis Clin North Am 2015.
36. Steere A., Auwaerter P., Mumford D. Lyme arthritis. Infect Dis Clin North Am 2015.
37. Sood S. Pediatric Lyme disease. Infect Dis Clin North Am 2015.
38. Marcus L.C., Steere A.C., Duray P.H., et al. Fatal pancarditis in a patient with coexistent Lyme disease and babesiosis. Demonstration of spirochetes in the myocardium. Ann Intern Med 1985, 103:374-376.
39. Kirsch M., Ruben F.L., Steere A.C., et al. Fatal adult respiratory distress syndrome in a patient with Lyme disease. JAm Med Assoc 1988, 259:2737-2739.
40. Waniek C., Prohovnik I., Kaufman M.A., et al. Rapidly progressive frontal-type dementia associated with Lyme disease. JNeuropsychiatry Clin Neurosci 1995, 7:345-347.
41. Tavora F., Burke A., Li L., et al. Postmortem confirmation of Lyme carditis with polymerase chain reaction. Cardiovasc Pathol 2008, 17:103-107.
42. Kugeler K.J., Griffith K.S., Gould L.H., et al. Areview of death certificates listing Lyme disease as a cause of death in the United States. Clin Infect Dis 2011, 52:364-367.
43. CDC Three sudden cardiac deaths associated with Lyme carditis - United States, November 2012-July 2013. Morb Mortal Wkly Rep 2013, 62:993-996.
44. Cromley E.K., Cartter M.L., Mrozinski R.D., et al. Residential setting as a risk factor for Lyme disease in a hyperendemic region. Am J Epidemiol 1998, 147:472-477.
45. Falco R.C., Fish D. Prevalence of Ixodes dammini near the homes of Lyme disease patients in Westchester County, New York. Am J Epidemiol 1988, 127:826-830.
46. Klein J.D., Eppes S.C., Hunt P. Environmental and life-style risk factors for Lyme disease in children. Clin Pediatr (Phila) 1996, 35:359-363.
47. Maupin G.O., Fish D., Zultowsky J., et al. Landscape ecology of Lyme disease in a residential area of Westchester County, New York. Am J Epidemiol 1991, 133:1105-1113.
48. Neitzel D.F., Kemperman M.M. Tick-borne diseases in Minnesota: an update. Minn Med 2012, 95:41-44.
49. Orloski K.A., Campbell G.L., Genese C.A., et al. Emergence of Lyme disease in Hunterdon County, New Jersey, 1993: a case-control study of risk factors and evaluation of reporting patterns. Am J Epidemiol 1998, 147:391-397.
50. Rand P.W., Lubelczyk C., Lavigne G.R., et al. Deer density and the abundance of Ixodes scapularis (Acari: Ixodidae). JMed Entomol 2003, 40:179-184.
51. Ley C., Olshen E.M., Reingold A.L. Case-control study of risk factors for incident Lyme disease in California. Am J Epidemiol 1995, 142:S39-S47.
52. Smith G., Wileyto E.P., Hopkins R.B., et al. Risk factors for Lyme disease in Chester County, Pennsylvania. Public Health Rep 2001, 116(Suppl 1):146-156.
53. Connally N.P., Durante A.J., Yousey-Hindes K.M., et al. Peridomestic Lyme disease prevention: results of a population-based case-control study. Am J Prev Med 2009, 37:201-206.
54. Schwartz B.S., Goldstein M.D. Lyme disease in outdoor workers: risk factors, preventive measures, and tick removal methods. Am J Epidemiol 1990, 131:877-885.
55. Ai C.X., Zhang W.F., Zhao J.H. Sero-epidemiology of Lyme disease in an endemic area in China. Microbiol Immunol 1994, 38:505-509.
56. Nakama H., Muramatsu K., Uchikama K., et al. Possibility of Lyme disease as an occupational disease- seroepidemiological study of regional residents and forestry workers. Asia Pac J Public Health 1994, 7:214-217.
57. Kaya A.D., Parlak A.H., Ozturk C.E., et al. Seroprevalence of Borrelia burgdorferi infection among forestry workers and farmers in Duzce, north-western Turkey. New Microbiol 2008, 31:203-209.
58. Buczek A., Rudek A., Bartosik K., et al. Seroepidemiological study of Lyme borreliosis among forestry workers in southern Poland. Ann Agric Environ Med 2009, 16:257-261.
59. Bilski B. Occurrence of cases of borreliosis certified as an occupational disease in the province of Wielkopolska (Poland). Ann Agric Environ Med 2009, 16:211-217.
60. Cinco M., Barbone F., Grazia Ciufolini M., et al. Seroprevalence of tick-borne infections in forestry rangers from northeastern Italy. Clin Microbiol Infect 2004, 10:1056-1061.
61. Hubalek Z. Epidemiology of Lyme borreliosis. Curr Probl Dermatol 2009, 37:31-50.
62. des Vignes F., Piesman J., Heffernan R., et al. Effect of tick removal on transmission of Borrelia burgdorferi and Ehrlichia phagocytophila by Ixodes scapularis nymphs. JInfect Dis 2001, 183:773-778.
63. Vazquez M., Muehlenbein C., Cartter M., et al. Effectiveness of personal protective measures to prevent Lyme disease. Emerg Infect Dis 2008, 14:210-216.
64. Johnson S.E., Swaminathan B., Moore P., et al. Borrelia burgdorferi: survival in experimentally infected human blood processed for transfusion. JInfect Dis 1990, 162:557-559.
65. McQuiston J.H., Childs J.E., Chamberland M.E., et al. Transmission of tick-borne agents of disease by blood transfusion: a review of known and potential risks in the United States. Transfusion 2000, 40:274-284.
66. CDC Anaplasma phagocytophilum transmitted through blood transfusion-Minnesota, 2007. MMWR Morb Mortal Wkly Rep 2008, 57:1145-1148.
67. Woodrum J.E., Oliver J.H. Investigation of venereal, transplacental, and contact transmission of the Lyme disease spirochete, Borrelia burgdorferi, in Syrian hamsters. JParasitol 1999, 85:426-430.
68. Moody K.D., Barthold S.W. Relative infectivity of Borrelia burgdorferi in Lewis rats by various routes of inoculation. Am J Trop Med Hyg 1991, 44:135-139.
69. Schlesinger P.A., Duray P.H., Burke B.A., et al. Maternal-fetal transmission of the Lyme disease spirochete, Borrelia burgdorferi. Ann Intern Med 1985, 103:67-68.
70. Figueroa R., Bracero L.A., Aguero-Rosenfeld M., et al. Confirmation of Borrelia burgdorferi spirochetes by polymerase chain reaction in placentas of women with reactive serology for Lyme antibodies. Gynecol Obstet Invest 1996, 41:240-243.
71. Markowitz L.E., Steere A.C., Benach J.L., et al. Lyme disease during pregnancy. JAm Med Assoc 1986, 255:3394-3396.
72. Walsh C.A., Mayer E.W., Baxi L.V. Lyme disease in pregnancy: case report and review of the literature. Obstet Gynecol Surv 2007, 62:41-50.
73. CDC. Nationally Notifiable Diseases Surveillance System (NNDSS). 2014. Available at: Accessed November 2, 2014. http://wwwn.cdc.gov/NNDSS/script/casedefDefault.aspx.
74. CSTE. Lyme disease surveillance case definition. 2011. Available at: Accessed November 2, 2014. http://wwwn.cdc.gov/NNDSS/script/conditionsummary.aspx?CondID=100.
75. Adams D.A., Jajosky R.A., Ajani U., et al. Summary of notifiable diseases-United States, 2012. MMWR Morb Mortal Wkly Rep 2014, 61:1-121.
76. CDC Notice to readers: final 2013 reports of nationally notifiable infectious diseases. MMWR Morb Mortal Wkly Rep 2014, 63:702-715.
77. Connecticut Department of Public Health Lyme disease - Connecticut, 2008. Connecticut Epidemiologist 2009, 29:14-16.
78. Ogden N.H., Lindsay L.R., Morshed M., et al. The emergence of Lyme disease in Canada. Can Med Assoc J 2009, 180:1221-1224.
79. Public Health Agency of Canada. Lyme disease. Surveillance. 2014; Available at: Accessed December 20, 2014. http://www.phac-aspc.gc.ca/id-mi/lyme/surveillance-eng.php.
80. Gordillo-Perez G., Vargas M., Solorzano-Santos F., et al. Demonstration of Borrelia burgdorferi sensu stricto infection in ticks from the northeast of Mexico. Clin Microbiol Infect 2009, 15:496-498.
81. Gordillo-Perez G., Torres J., Solorzano-Santos F., et al. Borrelia burgdorferi infection and cutaneous Lyme disease, Mexico. Emerg Infect Dis 2007, 13:1556-1558.
82. Mead P., Goel R., Kugeler K. Canine serology as adjunct to human Lyme disease surveillance. Emerg Infect Dis 2011, 17:1710-1712.
83. Bowman D., Little S.E., Lorentzen L., et al. Prevalence and geographic distribution of Dirofilaria immitis, Borrelia burgdorferi, Ehrlichia canis, and Anaplasma phagocytophilum in dogs in the United States: results of a national clinic-based serologic survey. Vet Parasitol 2009, 160:138-148.
84. IDEXX. Sensitivity and specificity of the SNAP® 4Dx® Test 2010. Available at:. Accessed October 1, 2010. http://www.idexx.com/view/xhtml/en_us/smallanimal/inhouse/snap/4dx.jsf?selectedTab=Accuracy#tabs.
85. Duncan A.W., Correa M.T., Levine J.F., et al. The dog as a sentinel for human infection: prevalence of Borrelia burgdorferi C6 antibodies in dogs from southeastern and mid-Atlantic States. Vector Borne Zoonotic Dis 2005, 5:101-109.
86. Fulop B., Poggensee G. Epidemiological situation of Lyme borreliosis in Germany: surveillance data from six Eastern German States, 2002 to 2006. Parasitol Res 2008, 103(Suppl 1):S117-S120.
87. Berglund J., Eitrem R., Ornstein K., et al. An epidemiologic study of Lyme disease in southern Sweden. NEngl J Med 1995, 333:1319-1327.
88. Centers for Disease Control and Prevention (CDC) Lyme disease-United States, 2001-2002. MMWR Morb Mortal Wkly Rep 2004, 53:365-369.
89. Tugwell P., Dennis D.T., Weinstein A., et al. Laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med 1997, 127:1109-1123.
90. Ai C.X., Hu R.J., Hyland K.E., et al. Epidemiological and aetiological evidence for transmission of Lyme disease by adult Ixodes persulcatus in an endemic area in China. Int J Epidemiol 1990, 19:1061-1065.
91. Falco R.C., McKenna D.F., Daniels T.J., et al. Temporal relation between Ixodes scapularis abundance and risk for Lyme disease associated with erythema migrans. Am J Epidemiol 1999, 149:771-776.
92. Lindgren E, Jaenson T. Lyme borreliosis in Europe: influences of climate and climate change, epidemiology, ecology and adaptation measures. 2006; 34. Available at: Accessed 1 October 2010. http://www.euro.who.int/__data/assets/pdf_file/0006/96819/E89522.pdf.
93. Alekseev A.N., Dubinina H.V. Abiotic parameters and diel and seasonal activity of Borrelia-infected and uninfected Ixodes persulcatus (Acarina: Ixodidae). JMed Entomol 2000, 37:9-15.
94. Eisen L., Eisen R.J., Lane R.S. Seasonal activity patterns of Ixodes pacificus nymphs in relation to climatic conditions. Med Vet Entomol 2002, 16:235-244.
95. Moore S.M., Eisen R.J., Monaghan A., et al. Meteorological influences on the seasonality of Lyme disease in the United States. Am J Trop Med Hyg 2014, 90:486-496.
96. Stanek G., Flamm H., Groh V., et al. Epidemiology of Borrelia infections in Austria. Zentralbl Bakteriol Mikrobiol Hyg A 1987, 263:442-449.
97. Strle F. Lyme borreliosis in Slovenia. Zentralbl Bakteriol Mikrobiol Hyg A 1999, 289:643-652.
98. Coyle B.S., Strickland G.T., Liang Y.Y., et al. The public health impact of Lyme disease in Maryland. JInfect Dis 1996, 173:1260-1262.
99. Meek J.I., Roberts C.L., Smith E.V., et al. Underreporting of Lyme disease by Connecticut physicians, 1992. JPublic Health Manag Pract 1996, 2:61-65.
100. Campbell G.L., Fritz C.L., Fish D., et al. Estimation of the incidence of Lyme disease. Am J Epidemiol 1998, 148:1018-1026.
101. Naleway A.L., Belongia E.A., Kazmierczak J.J., et al. Lyme disease incidence in Wisconsin: a comparison of state-reported rates and rates from a population-based cohort. Am J Epidemiol 2002, 155:1120-1127.
102. Doyle T.J., Glynn M.K., Groseclose S.L. Completeness of notifiable infectious disease reporting in the United States: an analytical literature review. Am J Epidemiol 2002, 155:866-874.
103. Rauter C., Hartung T. Prevalence of Borrelia burgdorferi sensu lato genospecies in Ixodes ricinus ticks in Europe: a meta-analysis. Appl Environ Microbiol 2005, 71:7203-7216.
104. EUCALB. European Union Concerted Action on Lyme Borreliosis. 2014. Available at: Accessed October 1, 2014. http://www.eucalb.com.
105. EpiNorth. A co-operation project for communicable disease control in Northern Europe. EpiNorth Data: Lyme borreliosis. 2014. Available at: Accessed July 10, 2014. http://www.epinorth.org.
106. Smith R., Takkinen J. Lyme borreliosis: Europe-wide coordinated surveillance and action needed?. Euro Surveill 2006, 11:E060622.1.
107. Hofhuis A., van der Giessen J.W., Borgsteede F.H., et al. Lyme borreliosis in the Netherlands: strong increase in GP consultations and hospital admissions in past 10 years. Euro Surveill 2006, 11:E060622.2.
108. Kampen H., Rotzel D.C., Kurtenbach K., et al. Substantial rise in the prevalence of Lyme borreliosis spirochetes in a region of western Germany over a 10-year period. Appl Environ Microbiol 2004, 70:1576-1582.
109. Korenberg E. Comparative ecology and epidemiology of Lyme disease and tick-borne encephalitis in the former Soviet Union. Parasitol Today 1994, 4:157-160.
110. Korenberg E., Gorelova N., Kovalevskii Y. Ecology of Borrelia burgdorferi sensu lato in Russia. Lyme borreliosis: biology, epidemiology and control 2002, 175-200. CABI Publishing, New York. J.S. Gray, O. Kahl, R.S. Lane (Eds.).
111. Masuzawa T. Terrestrial distribution of the Lyme borreliosis agent Borrelia burgdorferi sensu lato in East Asia. Jpn J Infect Dis 2004, 57:229-235.
112. WHO workshop on Lyme borreliosis diagnosis and surveillance, Warsaw, Poland, 20-22 June 1995 (who/cds/vph/95141-1). Geneva (Switzerland): World Health Organization; 1995.
113. Chu C.Y., Jiang B.G., Liu W., et al. Presence of pathogenic Borrelia burgdorferi sensu lato in ticks and rodents in Zhejiang, south-east China. JMed Microbiol 2008, 57:980-985.
114. Zhang F., Gong Z., Zhang J., et al. Prevalence of Borrelia burgdorferi sensu lato in rodents from Gansu, northwestern China. BMC Microbiol 2010, 10:157.
115. Hao Q., Hou X., Geng Z., et al. Distribution of Borrelia burgdorferi sensu lato in China. JClin Microbiol 2010, 49(2):647-650.
116. Hashimoto S., Kawado M., Murakami Y., et al. Epidemics of vector-borne diseases observed in infectious disease surveillance in Japan, 2000-2005. JEpidemiol 2007, 17(Suppl):S48-S55.
117. Chao L.L., Chen Y.J., Shih C.M. First detection and molecular identification of Borrelia garinii isolated from human skin in Taiwan. JMed Microbiol 2010, 59:254-257.
118. Russell R.C. Lyme disease in Australia-still to be proven!. Emerg Infect Dis 1995, 1:29-31.
119. Mantovani E., Costa I.P., Gauditano G., et al. Description of Lyme disease-like syndrome in Brazil. Is it a new tick borne disease or Lyme disease variation?. Braz J Med Biol Res 2007, 40:443-456.
120. Stanek G., Hirschl A., Stemberger H., et al. Does Lyme borreliosis also occur in tropical and subtropical areas?. Zentralbl Bakteriol Mikrobiol Hyg A 1987, 263:491-495.
121. Miranda J., Mattar S., Perdomo K., et al. Seroprevalence of Lyme borreliosis in workers from Cordoba, Colombia. Rev Salud Publica (Bogota) 2009, 11:480-489. [in Spanish].
122. Santos M., Ribeiro-Rodrigues R., Lobo R., et al. Antibody reactivity to Borrelia burgdorferi sensu stricto antigens in patients from the Brazilian Amazon region with skin diseases not related to Lyme disease. Int J Dermatol 2010, 49:552-556.
123. Cooper J.D., Feder H.M. Inaccurate information about Lyme disease on the internet. Pediatr Infect Dis J 2004, 23:1105-1108.
124. Huppertz H.I., Bohme M., Standaert S.M., et al. Incidence of Lyme borreliosis in the Wurzburg region of Germany. Eur J Clin Microbiol Infect Dis 1999, 18:697-703.
125. Schwarzwalder A., Schneider M.F., Lydecker A., et al. Sex differences in the clinical and serologic presentation of early Lyme disease: results from a retrospective review. Gend Med 2010, 7:320-329.
126. Henningsson A.J., Malmvall B.E., Ernerudh J., et al. Neuroborreliosis-an epidemiological, clinical and healthcare cost study from an endemic area in the south-east of Sweden. Clin Microbiol Infect 2010, 16:1245-1251.
127. Asbrink E., Brehmer-Andersson E., Hovmark A. Acrodermatitis chronica atrophicans-a spirochetosis. Clinical and histopathological picture based on 32 patients; course and relationship to erythema chronicum migrans Afzelius. Am J Dermatopathol 1986, 8:209-219.
128. Strle F., Wormser G.P., Mead P., et al. Gender disparity between cutaneous and non-cutaneous manifestations of Lyme borreliosis. PLoS One 2013, 8:e64110.
129. Ruzic-Sabljic E., Lotric-Furlan S., Maraspin V., et al. Analysis of Borrelia burgdorferi sensu lato isolated from cerebrospinal fluid. APMIS 2001, 109:707-713.
130. Ruzic-Sabljic E., Arnez M., Lotric-Furlan S., et al. Genotypic and phenotypic characterisation of Borrelia burgdorferi sensu lato strains isolated from human blood. JMed Microbiol 2001, 50:896-901.
131. van Dam A., Kuiper H., Vos K., et al. Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis 1993, 17:708-717.
132. Ornstein K., Berglund J., Nilsson I., et al. Characterization of Lyme borreliosis isolates from patients with erythema migrans and neuroborreliosis in southern Sweden. JClin Microbiol 2001, 39:1294-1298.
133. Steere A.C., Glickstein L. Elucidation of Lyme arthritis. Nat Rev Immunol 2004, 4:143-152.
134. Letrilliart L., Ragon B., Hanslik T., et al. Lyme disease in France: a primary care-based prospective study. Epidemiol Infect 2005, 133:935-942.
135. Makhani N., Morris S.K., Page A.V., et al. Atwist on Lyme: the challenge of diagnosing European Lyme neuroborreliosis. JClin Microbiol 2010, 49(1):455-457.
136. Bacon R.M., Biggerstaff B.J., Schriefer M.E., et al. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. JInfect Dis 2003, 187:1187-1199.
137. Kalish R.A., Kaplan R.F., Taylor E., et al. Evaluation of study patients with Lyme disease, 10-20-year follow-up. JInfect Dis 2001, 183:453-460.
138. Hayes E.B., Piesman J. How can we prevent Lyme disease?. NEngl J Med 2003, 348:2424-2430.
139. Plotkin S.A. Correcting a public health fiasco: the need for a new vaccine against Lyme disease. Clin Infect Dis 2011, 52(Suppl 3):s271-s275.
140. Piesman J., Eisen L. Prevention of tick-borne diseases. Annu Rev Entomol 2008, 53:323-343.
141. Vaughn M.F., Meshnick S.R. Pilot study assessing the effectiveness of long-lasting permethrin-impregnated clothing for the prevention of tick bites. Vector Borne Zoonotic Dis 2011, 11:869-875.
142. Stafford K. The tick management handbook: an integrated guide for homeowners, pest control operators, and public health officials for the prevention of tick-associated disease 2004, Connecticut Agricultural Experiment Station, New Haven (CT).
143. Wormser G.P., Dattwyler R.J., Shapiro E.D., et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006, 43:1089-1134.
144. Ogden N.H., Lindsay L.R., Morshed M., et al. The rising challenge of Lyme borreliosis in Canada. Can Commun Dis Rep 2008, 34:1-19.
145. Vandenesch A., Turbelin C., Couturier E., et al. Incidence and hospitalisation rates of Lyme borreliosis, France, 2004 to 2012. Euro Surveill 2014, 19:34.
146. Smith R., O'Connell S. Lyme borreliosis trends in England and Wales: 2005-2009. 12th International Conference on Lyme Borreliosis and other Tick-borne Diseases 2010, Austrian Society for Hygiene, Microbiology, and Preventive Medicine, Ljubljana (Slovenia).
147. Svihrova V., Hudeckova H., Jesenak M., et al. Lyme borreliosis-analysis of the trends in Slovakia, 1999-2008. Folia Microbiol (Praha) 2011, 56:270-275.
148. Portillo A., Santibanez S., Oteo J.A. Lyme disease. Enferm Infecc Microbiol Clin 2014, 32(Suppl 1):37-42. [in Spanish].
149. Berglund J., Eitrem R., Norrby S.R. Long-term study of Lyme borreliosis in a highly endemic area in Sweden. Scand J Infect Dis 1996, 28:473-478.